Browse courses by:
By: Rishi Singh, MD; Charles C. Wykoff, MD, PhD
This course has expired. You can still review the content but course credit is no longer available.
This educational activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
Upon completion of this activity, the participant should be able to:
Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Rishi P. Singh, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Allergan Inc.; Carl Zeiss Meditec; Genentech, Inc; Optos; Regeneron Pharmaceuticals, Inc; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech, Inc; and Regeneron Pharmaceuticals, Inc.
Charles Wykoff, MD, PhD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of: Consultant: Alimera Sciences, Inc.; Allergan, plc; Alnylam; Bayer Pharmaceuticals; Clearside Biomedical, Inc.; CORCEPT; DORC International; EyePoint/pSivida; Genentech, Inc.; Notal Vision; Novartia; ONL Therapeutics; Regeneron Pharmaceuticals, Inc; Roche; and Santen Pharmaceuticals. Speaker’s Bureau: Allergan, plc. and Regeneron Pharmaceuticals, Inc. Grant/Research Support: Adverum; Aerpio; Alcon; Aldeyra; Allegro Ophthalmics; Allergan, Inc.; Apellis Pharmaceuticals; Astellas; Aura; Boehringer Ingelheim; Chiltern; Clearside Biomedical, Inc.; EyePoint/pSivida; Genentech, Inc; Heidleberg; Iconic Therapeutics; John’s Hopkins University; NEI; Novartis; OHR; Opthotech Corporation; Regeneron Pharmaceuticals, Inc; Regenxbio; Roche; Santen Pharmaceutical Co., Ltd.; SciFlour; Taiwan Liposome Company; and Tyrogenex.
EDITORIAL SUPPORT DISCLOSURES
Erin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests.
Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests.
Jaya Kumar, MD, peer reviewer, has no financial relationships with commercial interests.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.